A. Dumoulin et al., Transmission of Pneumocystis carinii disease from immunocompetent contactsof infected hosts to susceptible hosts, EUR J CL M, 19(9), 2000, pp. 671-678
Citations number
48
Categorie Soggetti
Microbiology
Journal title
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Pneumocystis carinii organisms constitute a large group of heterogeneous at
ypical microscopic fungi that are able to infect immunocompromised mammals
by an airborne route and to proliferate in their lungs, inducing Pneumocyst
is carinii pneumonia. This pneumonia remains a crucial epidemiological chal
lenge, since neither the source of Pneumocystis carinii infection in humans
nor the process by which humans become infected has been clearly establish
ed. Polymerase chain reaction (PCR) assays have shown that profoundly immun
osuppressed patients without pneumocystosis can be subclinically infected w
ith Pneumocystis. Other PCR-based studies have suggested that healthy immun
ocompetent hosts are not latent carriers of the parasite. However, recent r
eports have indicated that Pneumocystis carinii can persist for limited per
iods in the lungs of convalescent rats after recovery from corticosteroid-i
nduced pneumocystosis, and also that immunocompetent mammals can be transie
ntly parasitized by Pneumocystis carinii after close contact with hosts wit
h Pneumocystis carinii pneumonia. Can transiently parasitized hosts be a so
urce of infection for immunosuppressed hosts? In order to investigate this
important clinical question: the ability of immunocompetent BALB/c mice, wh
ich were carrying subclinical levels of Pneumocystis carinii, to transmit t
he infection by the airborne route to highly susceptible, uninfected mice w
ith severe combined immunodeficiency was studied. The results indicated tha
t the immunocompetent mice, transiently parasitized by Pneumocystis carinii
organisms after close contact with Pneumocystis carinii-infected mice, wer
e able to transmit the infection to Pneumocystis carinii-free mice with sev
ere combined immunodeficiency.